206 results about "Cutaneous condition" patented technology

The present invention concerns a method and a kit, for the treatment of a selected area of the skin and / or subcutaneous tissue, and in particular for the cosmetic treatment of skin conditions such as regional fat deposits including cellulite. The method comprises heating the selected area to a sustained skin temperature of about 32 to about 50° C. for a desired period of time, using a device comprising either a heat source capable of conductively heating the selected area or, alternatively, an infra-red source for emitting infra-red with a wavelength from about 700 nm to about 15000 nm. The method also comprises administering, simultaneously or sequentially in either order, a composition containing an active agent selected from the group comprising a skin active, a nutrient absorption suppressant or a thermogenic agent, preferably a metabolic stimulating agent, more preferably a lipolytic agent, or a mixture thereof, the composition being either a topical composition for application to the selected area, or an area adjacent thereto, or an oral composition.

The present disclosure provides a variety of systems, techniques and machine readable programs for using plasmas to treat different skin conditions as well as other conditions, such as tumors, bacterial infections and the like.

The present invention is directed toward anti-aging skin care compositions comprising Vitamin B1, Vitamin B5, Vitamin C, N-acetyl-cysteine and, optionally, lipoic acid. The present invention is further directed toward methods for therapeutically or prophylactically treating the consequences of aging on the condition or appearance of the skin. The present invention further provides one or more kits that are useful for delaying, treating or preventing the consequences of aging on the condition or appearance of the skin.

The present invention provides topical compositions containing phosphorylated polyphenols in combination with a topically acceptable carrier. The compositions of the invention provide a means for delayed delivery of the polyphenol to keratinous tissues, such as skin, hair and nails, with enzymes of the keratinous tissue dephosphorylating the polyphenol, and returning it to its native active form. The compositions are particularly useful in the regulation of skin conditions.

The present invention is drawn to adhesive solidifying formulations for treating skin disorders, such as dermatitis or psoriasis. The formulation can include a drug, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system including at least one volatile solvent, and a non-volatile solvent system including at least one non-volatile solvent, wherein the non-volatile solvent system is capable of facilitating the delivery of the drug at therapeutically effective rates over a sustained period of time. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.

A device and a method for thermal treatments of target material with various thermal interactions are disclosed. A preferred treatment includes Thermal Heat Shuttle that transports a predetermined known quota of energy to the target surface. In particular, the launching of thermal energy quanta from various energy sources in lumps of energy quanta and leading to the treatment and healing of a variety of skin conditions are disclosed.

A light wand includes light emitting diodes that transmit monochromatic light for a therapeutic response. The monochromatic light provides healing and relieves pain from such conditions as, for example, abrasions, cuts, wounds, acne, and other skin conditions. Pulsed light and / or a constant light stream are emitted from the wand under the user's control. Intensity of the light energy is also controlled by the user through a control pad on the light wand. The light wand is portable and dimensioned for consumer use.

Provided herein are methods, kits, and pharmaceutical compositions that include a PI3 kinase inhibitor for treating lupus, a fibrotic condition, or inflammatory myopathies and other conditions (e.g., skin conditions).

A system and method are provided for targeted and individualized delivery of multiple skin benefit agents to the skin of a user. The image of a predetermined treatment area of the user's skin is first captured by an imaging device. The captured image data is then analyzed by a computing device to generate a unique skin profile for the user, which is indicative of the skin conditions at the predetermined treatment area. Based on such skin profile, a printing device prints out one or more cosmetic delivery sheets that can be applied to the predetermined treatment area. Each of the cosmetic delivery sheets contains a substrate with multiple isolate, discrete regions, while at least two of the regions are imprinted with different skin benefit agents for treating different skin conditions of the predetermined treatment area according to the unique skin profile of the user.

This application relates to a stable pharmaceutical composition and methods for the cleansing of skin to facilitate the prevention, treatment, and management of skin conditions, such as seborrheic dermatitis, psoriasis, folliculitis, rosacea, perioral dermatitis, acne, impetigo and other inflammatory skin conditions, and the like, including a sufficient amount of an acidic component of a hydroxyacid or tannic acid, or a pharmaceutically acceptable salt thereof, to exfoliate a portion of the skin, a sufficient amount of stabilized hydrogen peroxide to facilitate cleansing of the skin without substantial irritation thereof, and an antimicrobial agent including at least one of an antibacterial agent, antimicrobial agent, antiviral agent, anthelmintic, or a combination thereof, in an amount sufficient to inhibit or reduce microorganisms on the skin.

Topical compositions and methods of using same for treating various skin disorders or conditions. In a particular aspect, these compositions comprise a storage-stable mixture of a benzoyl peroxide-containing composition, an antibiotic or a pharmaceutically acceptable salt or ester thereof, and a retinoid or a pharmaceutically acceptable salt thereof. In an alternative embodiment, these compositions comprise a storage-stable mixture of a retinoid or a pharmaceutically acceptable salt thereof and either a benzoyl peroxide-containing composition or an antibiotic or a pharmaceutically acceptable salt or ester thereof.

Compositions, kits and methods are provided for restoring skin barrier function to skin exposed to environmental elements and / or in a pathological condition. In general, divalent cations such as calcium ions and / or magnesium ions are included in a physiologically acceptable medium. In some embodiments, divalent cations are balanced with monovalent cations such as sodium and potassium ions at appropriate ratios in order to maintain the homeostasis of skin barrier. The compositions, kits and methods can be used as cosmetics, cosmeceuticals or pharmaceuticals for improving skin condition, and preventing or treating dermatological diseases and skin disorders.

The present invention provides methods and compositions designed for treating a subject suffering from skin conditions, disorders or diseases. The compositions include fetal skin cell proteins obtained from fetal skin cells after induced cell lysis.

The present invention relates to compositions and methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and / or eliminating fine lines and / or wrinkles of skin, where the compositions include natural plant constituents which increase expression levels genes associated with the dermatological signs of aging. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof, once daily in an amount effective in improving the condition and aesthetic appearance of skin.

A resistant to body fluids, organic oil-based topical transdermal composition for the alleviation and treatment of infant skin conditions, including, dry, sensitive, chapped, cracked, itching reddened, and flaking skin, as well as infant skin infirmities associated with eczema, dermatitis, and diaper rash, which has as main constituents, organic oil lipids, vitamin A, tocopheral linoleate, and tincture of benzoin, in an organic beeswax emulsifying base.

A skin condition relieving medication, which can be directly applied onto a skin condition prone area of a user, is provided for preventing infection and reducing inflammation and swelling, while allowing air to reach the skin condition prone area in order to dry the skin condition and eventually healing the skin condition, wherein the skin condition relieving medication includes a predetermined amount of primary herb mixture including one or more herbs chosen from forsythia, frankincense, myrrh, cuttlefish bone, honeysuckle, turmeric and garden angelica, provided for the treating of the skin conditions, a predetermined amount of catalyst including vitamin E, and a predetermined amount of binding agent, which most suitably is Vaseline containing the primary herb mixture and the catalyst, and binding the primary herb mixture to the skin condition prone area of the user.

PCT No. PCT / US97 / 11564 Sec. 371 Date Apr. 14, 1999 Sec. 102(e) Date Apr. 14, 1999 PCT Filed Jul. 8, 1997 PCT Pub. No. WO98 / 01132 PCT Pub. Date Jan. 15, 1998The present invention relates to specific adamantyl or adamantyl group derivative containing retinoid compounds induce apoptosis of cancer cells. These adamantyl retinoid derivatives are useful for the treatment of many cancers and solid tumors, especially androgen-independent prostate cancer, skin cancer, pancreatic carcinomas, colon cancer, melanoma, ovarian cancer, liver cancer, small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, brain cancer, bladder cancer, breast cancer, neuroblastoma / glioblastoma, and leukemia. Also, the invention relates to novel adamantyl or adamantyl group derivative compounds which are useful as active agents for the treatment or prevention of keratinization disorders and other dermatological conditions, and other diseases.

The present application discloses a method of applying electromagnetic radiation, preferably laser radiation, most preferably at differing wavelengths, to reduce the severity of the symptoms of lipodermatosclerosis, for example. The method can reduce the severity of cutaneous and subcutaneous induration, hyperpigmentation, hyperhidrosis or other fluid weeping from the skin, erythematous, leathery appearance and texture, and associated pain and discomfort. The most preferred method involves non-invasively painting the affected area with an Aura-i laser (532 nm wavelength, generally penetrating the skin at a depth of 3-4 mm) through sapphire cooling disks and with a Lyra-i laser (1064 nm wavelength, generally penetrating the skin more deeply, such as at a depth of 6-7 mm) also through sapphire cooling disks. The method preferably involves at least three such painting applications separated by two to six, and preferably four, week intervals.

A method for at least one of characterizing, diagnosing, and treating a cutaneous condition in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the cutaneous condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the cutaneous condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.

The present invention relates to compositions and methods for treating, preventing and improving the condition and / or aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and / or eliminating fine lines and / or wrinkles of skin, where the compositions include active agents which increase expression levels of genes associated with the dermatological signs of aging. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof, once daily in an amount effective in improving the condition and / or aesthetic appearance of skin.

Method and apparatus to cause the cessation of hair growth on a specific area of the body and for the treatment of unwanted dermatological conditions. The area of treatment is exposed to a particular pattern and wavelength of light generated by multiple flashlamps, which allow simultaneous, overlap, or consecutive firing. Controlling the intensity of light, the output wavelength and the delay between pulses allow treatment to be adjusted to different skin conditions and hair types. Skin damage is virtually eliminated by the length and characteristic shape of the individual pulse of light.

A handheld probe treats acne and other skin conditions using a combination of optical and thermal therapy. The device contains light emitting devices capable of impinging a treatment area with laser light. In the preferred embodiment, the light emitting devices emit a combination of red and blue light to treat acne causing bacteria and prevent inflammation. The emitted light can be formed into therapeutically effective shapes by one or more optical arrangements. The device also contains a thermally conductive plate heated by a heater. The thermally conductive plate contacts the skin and warms it, enlarging the pores in the treatment area. One or more contact switches activate the device when brought into or near contact with the treatment area. In the preferred embodiment, the device is powered by a rechargeable battery.

Disclosed are topical compositions providing a high level of hydration and which comprise a vitamin B.sub.3 compound and a conditioning component for regulating the condition of skin.

Provided is a skin condition evaluation method. The skin condition evaluation method may include preparing a light source including one or more LEDs, irradiating light onto skin using the light source, and receiving light emitted through the skin using a light detector.

A method and apparatus for treatment of health and skin conditions through the use of a combination of laser systems or a laser system capable of delivering different pulse durations. The laser system being capable of producing both Q-switched short pulsed laser energy and millisecond long pulsed laser energies. Multiple skin conditions would be susceptible to this treatment, including acne, skin aging and textural changes, pigmentary changes, scarring, rosacea, striae, redness and hair removal.

The present invention relates to methods for characterization of bacterial skin microbiota to provide diagnostic, therapeutic, and preventive measures for alleviating skin conditions. In certain embodiments, the invention relates to characterization of bacterial skin microbiota associated with psoriasis and related diagnostic, therapeutic, and preventive measures for alleviating psoriasis. These methods will be useful for detecting, diagnosing, and monitoring individuals who have or are at risk of certain skin conditions.

The present invention relates to a novel approach means of screening various skin surfaces, including hard to reach areas of the human body, as well as more commonly seen areas such as the foot. The present invention can help patients, especially those who are immobile or those with diabetes self-monitor and transmit the skin condition accurately, so that medical providers may assess the risk or presence of skin tissue breakdown. Thus, provision is made for a remote screening device that can be used in telemedicine or home self-monitoring approaches and offers high resolution image, without artifacts or other distortions that might arise from images taken of feet that have been compressed through standing and the like.

The present invention provides compositions and methods for treating hair loss, nail brittleness and skin conditions, and for promoting or enhancing hair growth. The composition generally includes at least one methionine analog or derivative. The invention further provides structured fluid delivery systems comprising the compositions of the invention.

The present invention provides a composition, method and kit for treating skin disorders and improving skin condition. The composition, method and kit is particularly suited for treating acne vulgaris, seborrhea, rosacea, hirsutism, psoriasis, oily skin, dry skin, discoloration, post inflammatory hyper pigmentation, sun spots, and wrinkles.